RCMI CLINICAL RESEARCH CENTER INFRASTRUCTURE INITATIVE

总体描述(改编自申请人的摘要)：续 通过RCMI临床研究基础设施请求支持 RCMI-CRC倡议。具体地说，要求继续提供支持 护理和饮食人员配备的增加，一个受过临床培训的 流行病学家/生物统计学家和HAC的扩大。原创基金 在德鲁申请RCMI-CRC是实现以下目标的关键第一步 在该机构扩大面向患者护理的研究机会。 从历史上看，RCMI-CRC在医学进步中发挥了重要作用， 从而为医疗实践和医疗质量设定标准 医疗保健。RCMI-CRC在德鲁的存在导致了 致力于临床研究的教师和项目的数量 调查对少数群体和 弱势群体。此外，RCMI-CRC的存在导致了 以增加德鲁和德鲁之间的合作临床研究活动 加州大学洛杉矶分校医学院，港湾/加州大学洛杉矶分校，南加州大学，MCW，西奈山医学院 纽约州中心、JHU和杜克大学。在RCMI支持的最初四年中， 德鲁大学面向患者护理的研究活动从8项增加到 12；公共卫生服务(PHS)；即国家卫生研究院(NIH)， 疾病控制中心(CDC)资助的临床研究(50% 增加)。最近又资助了另外五个项目以及 另有三份小灵通申请正在审核中。这些项目代表着一个 这对德鲁来说是个难得的机会。不幸的是，如果没有额外的 在得到支持的情况下，RCMI-CRC无法处理增加的需求。作为回应 要实现这一机构增长，增加资金对扩大RCRII至关重要- CRC容量。因此，此次续签申请的广泛目标是 扩大临床研究活动的广度，并保持不断增长的 在职临床研究人员的数量。

OVERALL DESCRIPTION (Adapted from the applicant's abstract): Continued support is requested through the RCMI Clinical Research Infrastructure initiative for the RCMI-CRC. Specifically, continued support is requested for the an increase in the nursing and dietary staffing, a clinically trained epidemiologist/biostatistician and expansion of the HAC. The original funded application for the RCMI-CRC at Drew was the first crucial step toward expanding patient care oriented research opportunities at the institution. Historically, RCMI-CRCs have played an influential role in medical advances, thereby setting standards for the practice of medicine and the quality of health care. The presence of a RCMI-CRC at Drew has led to an increase in the number of clinical research faculty and projects dedicated to the investigation of health issues that disproportionately affect minorities and disadvantaged populations. In addition, the presence of an RCMI-CRC has led to an increase in collaborative clinical research activities between Drew and the UCLA School of Medicine, Harbor/UCLA, USC, MCW, Mount Sinai Medical Center, N.Y., JHU, and Duke. During the initial four years of RCMI support, patient care oriented research activities have increased at Drew from eight to twelve; Public Health Service (PHS); i.e. National Institutes of Health (NIH), Centers for Disease Control (CDC)-funded clinical research studies (50 percent increase). An additional five projects have recently been funded as well as another three PHS applications under review. These projects represent an extraordinary opportunity for Drew. Unfortunately, without additional support, the RCMI-CRC is unable to handle the increased demand. In response to this institutional growth, increased funding is essential to expand RCRII- CRC capacity. As such, the broad objective of this renewal application is to expand the breadth of clinical research activities and sustain an increasing number of active clinical research faculty.